Clinical Trials Logo

Urinary Incontinence clinical trials

View clinical trials related to Urinary Incontinence.

Filter by:

NCT ID: NCT01029106 Terminated - Clinical trials for Stress Urinary Incontinence

Gynecare TVT Secur for the Management of Stress Urinary Incontinence (SUI)

Start date: September 2009
Phase: N/A
Study type: Observational

This is a prospective, non-randomized, observational, multicentre (5 sites) study in which subjects that have surgically-correctable Stress Urinary Incontinence undergo a TVT SECUR operative procedure. The study will collect preoperative urologic testing, medical history, and subject quality of life patient questionnaires, Intraoperative procedural data will be collected. Postoperative complications, urologic, testing, and subject questionnaires will be collected at intervals up to 24 months. The anatomic position of the device will be characterize by transvaginal ultrasound testing. To determine the rate and/or improvement rate of patients who have received the Gynecare Secur device after 12 months and after 24 months.

NCT ID: NCT01023269 Terminated - Clinical trials for Urinary Incontinence

Efficacy Study of Pudendal Neuromodulation for the Treatment of Neurogenic Overactive Bladder

ACCEPTANCE
Start date: December 2009
Phase: N/A
Study type: Interventional

The study is designed to demonstrate that treatment with low level stimulation of the bladder muscles reduces symptoms of urinary incontinence in comparison with no stimulation.

NCT ID: NCT01011777 Terminated - Clinical trials for Urinary Incontinence

Muscle Derived Cell Therapy for Bladder Exstrophy Epispadias Induced Incontinence

MDC
Start date: February 1, 2017
Phase: Phase 1
Study type: Interventional

The aim of this study is to study safety, tolerability and efficacy of muscle derived cell (MDC) therapy in children with bladder exstrophy epispadias induced urinary incontinence.

NCT ID: NCT01008943 Completed - Clinical trials for Stress Urinary Incontinence

Autologous Cell Therapy for Female Stress Urinary Incontinence

Start date: June 2, 2010
Phase: Phase 2
Study type: Interventional

The Autologous Cell Therapy for Female SUI study is a clinical trial to determine the safety and potential effectiveness of a single dose of 200 million Cook MyoSite Autologous Muscle Derived Cells for treatment of Stress Urinary Incontinence.

NCT ID: NCT00998790 Completed - Clinical trials for Stress Urinary Incontinence

A Post-Market Study of the AMS AdVanceā„¢ Male Sling System for the Treatment of Male Stress Urinary Incontinence

Start date: January 2007
Phase: N/A
Study type: Interventional

A prospective, multi-center study of the AdVance Male Sling for Stress Urinary Incontinence. The purpose of this study is to obtain surgical technique data for use in physician education and training and to collect early clinical outcomes data for future publication. This study is not designed to statistically demonstrate safety and efficacy of the device.

NCT ID: NCT00996489 Completed - Clinical trials for Female Stress Urinary Incontinence Due to Intrinsic Sphincter Deficiency

This is a Post Approval Study of Coaptite® in the Treatment of Female Urinary Incontinence

Start date: January 8, 2008
Phase: N/A
Study type: Interventional

This is a post approval study of Coaptite® in the treatment of female urinary incontinence.

NCT ID: NCT00982098 Active, not recruiting - Clinical trials for Urinary Incontinence

Prevention of Urinary Incontinence After Prostatectomy

Start date: February 2007
Phase: N/A
Study type: Interventional

Urinary incontinence is a frequent complication after radical prostatectomy. Rehabilitative treatments are frequently utilized to reduce incontinence. However, their efficacy has not been completely investigated. In this study the investigators will compare the effect of an early rehabilitation programme (instruction of the patient, pelvic floor muscle training, electrical stimulation and biofeedback) versus instruction of the patient only. The investigators hypothesis is that early rehabilitation programme is more effective than patient's instruction alone in preventing urinary incontinence after radical prostatectomy.

NCT ID: NCT00942370 Completed - Clinical trials for Stress Urinary Incontinence

Electromyographic (EMG) and Mechanomyographic (MMG) Comparison

EMG-MMG
Start date: July 2009
Phase: N/A
Study type: Observational

The purpose of this study is to assess the delay between the detection (by mechanomyography-MMG) of rectus abdominis contraction and the detection of cough in cough effort.

NCT ID: NCT00939432 Completed - Gender Differences Clinical Trials

Taboo Perception of Incontinence, Depression and Cancer

Start date: November 2005
Phase: N/A
Study type: Observational

Objective/study hypothesis To evaluate how much of a taboo UI is and how it compares to other medical conditions that may also pose a taboo issue like depression and cancer. Background Urinary incontinence (UI) is a highly prevalent condition with more than 200 million people worldwide being affected. While physical health does not necessarily have to be impaired much, restriction of social activities leads to isolation, a significant reduction in quality of life and will often bring about subsequent morbidity. Despite its prevalence, many patients suffering from UI go undiagnosed and untreated. Patients often hesitate to report the problem, and health care professionals often do not ask about it. In a study Minassian (2003) estimated that just one in four patients actively seeks medical attention. The reason for this may lie in the shame, embarrassment, and stigma associated with this condition, which in turn pose significant barriers to seeking professional treatment. Although mentioned by many narrative reviews and included in some epidemiological papers on UI, surprisingly we found no data addressing the taboo of UI exclusively. The aim of our study therefore was Methods/Design A 13-question self-administered questionnaire was developed and face validity tested by 2 of the authors (KH, EH). The anonymous questionnaire contained simple questions on gender and age and then asked yes/no questions on whether test persons knew people with UI, or suspected other people to be incontinent, if they would address this issue with the suspected person, and if they thought that UI was a taboo issue in the society. On a scale from 0 - 10 they were then asked to grade the amount of embarrassment and anxiety if they themselves were incontinent, compared to depression or cancer. A few questions on knowledge of the condition of UI and to whom test persons would turn to in case of UI concluded the short questionnaire, which took about 5 minutes to fill in. A convenience sample of 150 test persons from waiting areas of a teaching hospital and in private practices of general practitioners in Austria agreed to take part in the study, with an additional 10 persons (6.2%) declining after being informed about the subject. Data were analysed with the SPSS 10.0.5 software package using the U-test, Chi-square-test, Yates-correction, Fisher's exact test and Kolmogorov-Smirnov normality test where appropriate.

NCT ID: NCT00937833 Completed - Prostate Cancer Clinical Trials

Return of Continence Following Robot-Assisted Radical Prostatectomy With or Without a Urethrovesical Sling

Start date: November 2009
Phase: N/A
Study type: Interventional

The purpose of this study is to determine the impact of an absorbable urethrovesical sling on the post-operative return of urinary continence after robot-assisted radical prostatectomy.